Pacira BioSciences, Inc.
Pacira BioSciences, Inc. (PCRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PCRX · as of Jun 8, 2026
Key Statistics
Explore Pacira BioSciences, Inc. Data
pcrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 36 · Buy rate: 41.7%
The PCRX analyst consensus is Hold, based on ratings from 36 Wall Street analysts over the past 3 months. The average 12-month price target is $29.50, representing +29.05% upside from the current price of $22.86.
Competitors & Peers
pcrx competitorsPCRX
ANAB
BBOT
CRON
KOD
MNMDStock Performance
Full HistoryAbout Pacira BioSciences, Inc.
Pacira BioSciences, Inc. Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health…
what is pacira biosciences, inc. · pcrx stock overview · pacira biosciences, inc. company profile · who is pacira biosciences, inc. ceo · pcrx NASDAQ · pacira biosciences, inc. headquarters · pacira biosciences, inc. business segments
About Stock Overview & Key Data
Pacira BioSciences, Inc. (PCRX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Feb 3, 2011. As of the latest trading session, PCRX stock price is $22.86, with a market capitalization of $899.2M. The stock has returned -10.07% over the past 12 months and -11.67% year-to-date.
According to 36 Wall Street analysts, the consensus rating for Pacira BioSciences, Inc. stock is Hold, with an average 12-month price target of $29.50. In fiscal year 2025, Pacira BioSciences, Inc. reported revenue of $726.4M and net income of $7.0M. For detailed data — including Pacira BioSciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Pacira BioSciences, Inc. (PCRX) stock price is $22.86. The stock is traded on NASDAQ under the ticker symbol PCRX. The 52-week range is $18.80 – $27.64.